ACROBIOSYSTEMS CO.,LTD. — Investor Relations & Filings
ACROBIOSYSTEMS CO.,LTD. is a global biotechnology company specializing in the development and manufacturing of high-quality recombinant proteins and critical reagents for the life sciences industry. The company provides a comprehensive portfolio of products designed to accelerate the development of target therapeutics, including antibodies, cell and gene therapies, and vaccines. Key offerings include a wide range of biotinylated proteins, enzymes, and assay kits characterized by high bioactivity and batch-to-batch consistency. ACROBIOSYSTEMS supports drug discovery and clinical development through specialized platforms for protein engineering and characterization. Its products serve a diverse client base of pharmaceutical companies, biotechnology firms, and academic research institutions worldwide, focusing on therapeutic areas such as oncology, immunology, and infectious diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公司章程（2025年8月） | 2025-08-21 | Chinese | |
| 关联交易管理制度（2025年8月） | 2025-08-21 | Chinese | |
| 2025年半年度非经营性资金占用及其他关联资金往来情况汇总表 | 2025-08-21 | Chinese | |
| 关于变更注册资本、经营范围并修订《公司章程》及修订、制定部分制度的公告 | 2025-08-21 | Chinese | |
| 2025年半年度募集资金存放、管理与使用情况的专项报告 | 2025-08-21 | Chinese | |
| 对外担保管理制度（2025年8月） | 2025-08-21 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 44580885 | 公司章程（2025年8月） | 2025-08-21 | Chinese | ||
| 44580869 | 关联交易管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44580856 | 2025年半年度非经营性资金占用及其他关联资金往来情况汇总表 | 2025-08-21 | Chinese | ||
| 44580840 | 关于变更注册资本、经营范围并修订《公司章程》及修订、制定部分制度的公告 | 2025-08-21 | Chinese | ||
| 44580829 | 2025年半年度募集资金存放、管理与使用情况的专项报告 | 2025-08-21 | Chinese | ||
| 44580817 | 对外担保管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44580808 | 董事、高级管理人员所持公司股份及其变动管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44580799 | 远期结汇售汇及外汇期权业务管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44580785 | 内部审计制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44580769 | 独立董事工作制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44580758 | 董事会议事规则（2025年8月） | 2025-08-21 | Chinese | ||
| 44580750 | 信息披露管理制度（2025年8月） | 2025-08-21 | Chinese | ||
| 44580732 | 关于召开2025年第三次临时股东大会的通知 | 2025-08-21 | Chinese | ||
| 44580725 | 监事会决议公告 | 2025-08-21 | Chinese | ||
| 44580717 | 关于实际控制人之一致行动人及高级管理人员减持股份的预披露公告 | 2025-08-14 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ACROBIOSYSTEMS CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56034/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56034 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56034 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56034 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56034}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ACROBIOSYSTEMS CO.,LTD. (id: 56034)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.